Relying on the park's two core common technology platforms, "Chinese Hamster Ovary (CHO) Cell Efficient Expression System Platform" and "Antibody-Drug Coupling (ADC) Drug Development Key Technology Platform". These platforms provide the entire process and of customized services for the enterprises from early development, process development, clinical sample production, large-scale commercial production, IND / BLA declaration at home and abroad.